Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | |||
content:opsoclonus_myoclonus_ataxia_syndrome [2024/03/13 05:15] – biju.hameed@gmail.com | content:opsoclonus_myoclonus_ataxia_syndrome [2024/03/15 19:11] (current) – biju.hameed@gmail.com | ||
---|---|---|---|
Line 1: | Line 1: | ||
====== Opsoclonus Myoclonus Ataxia Syndrome ====== | ====== Opsoclonus Myoclonus Ataxia Syndrome ====== | ||
+ | {{page> | ||
^ Recommendations for the Dosing and Monitoring of Immunotherapeutic Agents in the Treatment of OMAS: Steroid Treatment and Ivig || | ^ Recommendations for the Dosing and Monitoring of Immunotherapeutic Agents in the Treatment of OMAS: Steroid Treatment and Ivig || | ||
| **Treatment of OMS in children** | | **Treatment of OMS in children** |